{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T20:54:54Z","timestamp":1761166494052,"version":"build-2065373602"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004366","name":"Tabriz University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004366","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Graphics and Modelling"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.jmgm.2019.107459","type":"journal-article","created":{"date-parts":[[2019,9,29]],"date-time":"2019-09-29T05:25:02Z","timestamp":1569734702000},"page":"107459","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Alignment independent 3D-QSAR studies and molecular dynamics simulations for the identification of potent and selective S1P1 receptor agonists"],"prefix":"10.1016","volume":"94","author":[{"given":"Ali Akbar","family":"Alizadeh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Behzad","family":"Jafari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siavoush","family":"Dastmalchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmgm.2019.107459_bib1","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.pharmthera.2007.04.006","article-title":"Sphingosine 1-phosphate receptors in health and disease: mechanistic insights from gene deletion studies and reverse pharmacology","volume":"115","author":"Brinkmann","year":"2007","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jmgm.2019.107459_bib2","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/j.bmcl.2010.01.102","article-title":"Discovery of a novel series of potent S1P1 agonists","volume":"20","author":"Crosignani","year":"2010","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.jmgm.2019.107459_bib3","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1126\/science.1215904","article-title":"Crystal structure of a lipid G protein-coupled receptor","volume":"335","author":"Hanson","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.jmgm.2019.107459_bib4","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1146\/annurev.biochem.78.072407.103733","article-title":"Sphingosine 1-phosphate receptor signaling","volume":"78","author":"Rosen","year":"2009","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.jmgm.2019.107459_bib5","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1177\/2040622315617354","article-title":"Ponesimod, a selective S1P1 receptor modulator: a potential treatment for multiple sclerosis and other immune-mediated diseases","volume":"7","author":"D\u2019Ambrosio","year":"2016","journal-title":"Ther. Adv. Chron. Dis."},{"key":"10.1016\/j.jmgm.2019.107459_bib6","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.bmcl.2014.11.089","article-title":"Design and synthesis of new tricyclic indoles as potent modulators of the S1P1 receptor","volume":"25","author":"Buzard","year":"2015","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.jmgm.2019.107459_bib7","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1021\/jm100181s","article-title":"2-imino-thiazolidin-4-one derivatives as potent, orally active S1P1 receptor agonists","volume":"53","author":"Bolli","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.jmgm.2019.107459_bib8","doi-asserted-by":"crossref","first-page":"4404","DOI":"10.1016\/j.bmcl.2012.04.129","article-title":"Fused tricyclic indoles as S1P(1) agonists with robust efficacy in animal models of autoimmune disease","volume":"22","author":"Buzard","year":"2012","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.jmgm.2019.107459_bib9","doi-asserted-by":"crossref","first-page":"A387","DOI":"10.1016\/j.autrev.2009.11.010","article-title":"Multiple sclerosis: geoepidemiology, genetics and the environment","volume":"9","author":"Milo","year":"2010","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jmgm.2019.107459_bib10","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1007\/s40265-014-0264-y","article-title":"Fingolimod: a review of its use in relapsing-remitting multiple sclerosis","volume":"74","author":"Sanford","year":"2014","journal-title":"Drugs"},{"key":"10.1016\/j.jmgm.2019.107459_bib11","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/j.1476-5381.2009.00451.x","article-title":"FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system","volume":"158","author":"Brinkmann","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jmgm.2019.107459_bib12","doi-asserted-by":"crossref","first-page":"4903","DOI":"10.1016\/j.bmcl.2004.07.030","article-title":"Synthesis of benzimidazole based analogues of sphingosine-1-phosphate: discovery of potent, subtype-selective S1P4 receptor agonists","volume":"14","author":"Clemens","year":"2004","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.jmgm.2019.107459_bib13","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1016\/j.bmcl.2005.05.097","article-title":"Synthesis of 4(5)-phenylimidazole-based analogues of sphingosine-1-phosphate and FTY720: discovery of potent S1P1 receptor agonists","volume":"15","author":"Clemens","year":"2005","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.jmgm.2019.107459_bib14","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/wcms.1150","article-title":"Molecular interaction fields in drug discovery: recent advances and future perspectives","volume":"3","author":"Artese","year":"2013","journal-title":"Wiley. Interdiscipl. Rev. Comput. Mol. Sci."},{"key":"10.1016\/j.jmgm.2019.107459_bib15","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.ejmech.2007.09.019","article-title":"GRIND-based 3D-QSAR to predict inhibitory activity for similar enzymes, OSC and SHC","volume":"43","author":"Ermondi","year":"2008","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jmgm.2019.107459_bib16","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/cem.2817","article-title":"An alignment-independent 3D-QSAR study on series of hydroxamic acid-based tumor necrosis factor-\u03b1 converting enzyme inhibitors","volume":"30","author":"Alizadeh","year":"2016","journal-title":"J.\u00a0Chemom."},{"key":"10.1016\/j.jmgm.2019.107459_bib17","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.ejmech.2010.12.024","article-title":"An application of two MIFs-based tools (Volsurf+ and Pentacle) to binary QSAR: the case of a palinurin-related data set of non-ATP competitive glycogen synthase kinase 3beta (GSK-3beta) inhibitors","volume":"46","author":"Ermondi","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jmgm.2019.107459_bib18","doi-asserted-by":"crossref","first-page":"409","DOI":"10.15171\/apb.2017.049","article-title":"An alignment-independent 3D-QSAR study of FGFR2 Tyrosine kinase inhibitors","volume":"7","author":"Jafari","year":"2017","journal-title":"Adv. Pharmaceut. Bull."},{"key":"10.1016\/j.jmgm.2019.107459_bib19","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1111\/bph.13476","article-title":"Ozanimod (RPC1063) is a potent sphingosine-1-phosphate receptor-1 (S1P1) and receptor-5 (S1P5) agonist with autoimmune disease-modifying activity","volume":"173","author":"Scott","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jmgm.2019.107459_bib20","doi-asserted-by":"crossref","first-page":"8127","DOI":"10.1021\/ja00467a001","article-title":"Conformational analysis. 130. MM2. A hydrocarbon force field utilizing V1 and V2 torsional terms","volume":"99","author":"Allinger","year":"1977","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.jmgm.2019.107459_bib21","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/jcc.540100208","article-title":"Optimization of parameters for semiempirical methods I. Method","volume":"10","author":"Stewart","year":"1989","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.jmgm.2019.107459_bib22","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1093\/nar\/gkg520","article-title":"SWISS-MODEL: an automated protein homology-modeling server","volume":"31","author":"Schwede","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jmgm.2019.107459_bib23","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1107\/S0907444909042073","article-title":"MolProbity: all-atom structure validation for macromolecular crystallography","volume":"66","author":"Chen","year":"2010","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"10.1016\/j.jmgm.2019.107459_bib24","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0076-6879(97)77022-8","article-title":"VERIFY3D: assessment of protein models with three-dimensional profiles","volume":"277","author":"Eisenberg","year":"1997","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.jmgm.2019.107459_bib25","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1107\/S0021889892009944","article-title":"PROCHECK: a program to check the stereochemical quality of protein structures","volume":"26","author":"Laskowski","year":"1993","journal-title":"J.\u00a0Appl. Crystallogr."},{"key":"10.1016\/j.jmgm.2019.107459_bib26","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0022-2836(95)80037-9","article-title":"Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation","volume":"245","author":"Jones","year":"1995","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.jmgm.2019.107459_bib27","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1006\/jmbi.1996.0897","article-title":"Development and validation of a genetic algorithm for flexible docking","volume":"267","author":"Jones","year":"1997","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.jmgm.2019.107459_bib28","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1002\/(SICI)1096-987X(19961115)17:14<1653::AID-JCC7>3.0.CO;2-K","article-title":"A\u00a0fast method of molecular shape comparison: a simple application of a Gaussian description of molecular shape","volume":"17","author":"GRANT","year":"1996","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.jmgm.2019.107459_bib29","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1021\/jm00145a002","article-title":"A\u00a0computational procedure for determining energetically favorable binding sites on biologically important macromolecules","volume":"28","author":"Goodford","year":"1985","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.jmgm.2019.107459_bib30","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1021\/ci800037t","article-title":"Development and validation of AMANDA, a new algorithm for selecting highly relevant regions in Molecular Interaction Fields","volume":"48","author":"Duran","year":"2008","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.jmgm.2019.107459_bib31","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1021\/jm000941m","article-title":"GRid-INdependent descriptors (GRIND): a novel class of alignment-independent three-dimensional molecular descriptors","volume":"43","author":"Pastor","year":"2000","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.jmgm.2019.107459_bib32","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.chemolab.2015.04.013","article-title":"On a simple approach for determining applicability domain of QSAR models","volume":"145","author":"Roy","year":"2015","journal-title":"Chemometr. Intell. Lab. Syst."},{"key":"10.1016\/j.jmgm.2019.107459_bib33","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1093\/bioinformatics\/btm404","article-title":"Clustal W and clustal X version 2.0","volume":"23","author":"Larkin","year":"2007","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jmgm.2019.107459_bib34","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and testing of a general amber force field","volume":"25","author":"Wang","year":"2004","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.jmgm.2019.107459_bib35","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/jcc.10128","article-title":"Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validation","volume":"23","author":"Jakalian","year":"2002","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.jmgm.2019.107459_bib36","doi-asserted-by":"crossref","first-page":"10269","DOI":"10.1021\/j100142a004","article-title":"A\u00a0well-behaved electrostatic potential based method using charge restraints for deriving atomic charges: the RESP model","volume":"97","author":"Bayly","year":"1993","journal-title":"J.\u00a0Phys. Chem."},{"key":"10.1016\/j.jmgm.2019.107459_bib37","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1002\/jcc.20945","article-title":"CHARMM-GUI: a web-based graphical user interface for CHARMM","volume":"29","author":"Jo","year":"2008","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.jmgm.2019.107459_bib38","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1021\/ct4010307","article-title":"Lipid14: the amber lipid force field","volume":"10","author":"Dickson","year":"2014","journal-title":"J.\u00a0Chem. Theory Comput."},{"key":"10.1016\/j.jmgm.2019.107459_bib39","first-page":"45","article-title":"Applicability domain for QSAR models: where theory meets reality","volume":"1","author":"Nicolotti","year":"2016","journal-title":"Int. J. Quant. Struct-Prop. Relatsh."},{"key":"10.1016\/j.jmgm.2019.107459_bib40","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1096\/fj.201800221R","article-title":"Sphingosine-1-phosphate (S1P) induces potent anti-inflammatory effects in\u00a0vitro and in\u00a0vivo by S1P receptor 4-mediated suppression of 5-lipoxygenase activity","volume":"33","author":"Fettel","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.jmgm.2019.107459_bib41","doi-asserted-by":"crossref","first-page":"39379","DOI":"10.1074\/jbc.M007680200","article-title":"Identification of Edg1 receptor residues that recognize sphingosine 1-phosphate","volume":"275","author":"Parrill","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jmgm.2019.107459_bib42","doi-asserted-by":"crossref","first-page":"49213","DOI":"10.1074\/jbc.M107301200","article-title":"A\u00a0single amino acid determines lysophospholipid specificity of the S1P1 (EDG1) and LPA1 (EDG2) phospholipid growth factor receptors","volume":"276","author":"Wang","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jmgm.2019.107459_bib43","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1124\/mol.108.049783","article-title":"Full pharmacological efficacy of a novel S1P1 agonist that does not require S1P-like headgroup interactions","volume":"74","author":"Gonzalez-Cabrera","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jmgm.2019.107459_bib44","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1021\/cb800051m","article-title":"Ligand-binding pocket shape differences between sphingosine 1-phosphate (S1P) receptors S1P1 and S1P3 determine efficiency of chemical probe identification by ultrahigh-throughput screening","volume":"3","author":"Schurer","year":"2008","journal-title":"ACS Chem. Biol."}],"container-title":["Journal of Molecular Graphics and Modelling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109332631930422X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109332631930422X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T21:01:56Z","timestamp":1761080516000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109332631930422X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":44,"alternative-id":["S109332631930422X"],"URL":"https:\/\/doi.org\/10.1016\/j.jmgm.2019.107459","relation":{},"ISSN":["1093-3263"],"issn-type":[{"type":"print","value":"1093-3263"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alignment independent 3D-QSAR studies and molecular dynamics simulations for the identification of potent and selective S1P1 receptor agonists","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Graphics and Modelling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmgm.2019.107459","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107459"}}